Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1367 USD | +3.25% | +3.01% | -76.83% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eric Konofal
FOU | Founder | 57 | 15-06-09 |
Alexander Zwyer
FOU | Founder | 54 | 15-06-09 |
Director of Finance/CFO | - | 23-05-19 | |
George Apostol
CTO | Chief Tech/Sci/R&D Officer | 51 | 22-09-07 |
David Moskowitz
IRC | Investor Relations Contact | - | - |
Hervé Girsault
PRN | Corporate Officer/Principal | 64 | 16-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Audrey Greenberg
BRD | Director/Board Member | 51 | 23-06-29 |
Alexander Zwyer
FOU | Founder | 54 | 15-06-09 |
Ronald Hafner
FOU | Founder | 60 | 15-06-09 |
Director/Board Member | 55 | 21-06-16 | |
Anthony Walsh
BRD | Director/Board Member | - | 23-06-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,806,136 | 27,083,431 ( 63.27 %) | 3,242,887 ( 7.576 %) | 63.27 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-76.83% | 6.44M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NLSP Stock
- Company NLS Pharmaceutics Ltd.